Veterinary Medicines

TYLOGRAN, 1000 mg/g, granules for use in drinking water/milk for cattle (calves), pigs, chickens and turkeys

Authorised
  • Tylosin tartrate
Download as PDF

Product identification

Medicine name:
TYLOGRAN, 1000 mg/g, granules for use in drinking water/milk for cattle (calves), pigs, chickens and turkeys
Tylogran 1000 mg/g rakeet juomaveteen/maitoon sekoitettavaksi
Active substance:
  • Tylosin tartrate
Target species:
  • Pig
  • Chicken
  • Cattle (calf)
  • Turkey
Route of administration:
  • In drinking water use
  • Oral use

Product details

Active substance and strength:
  • Tylosin tartrate
    1.10
    gram(s)
    /
    1.10
    gram(s)
Pharmaceutical form:
  • Granules for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Pig
      • Meat and offal
        1
        day
    • Chicken
      • Meat and offal
        1
        day
      • Egg
        no withdrawal period
    • Cattle (calf)
      • Meat and offal
        12
        day
    • Turkey
      • Meat and offal
        2
        day
      • Egg
        no withdrawal period
  • Oral use
    • Pig
      • Meat and offal
        1
        day
    • Chicken
      • Meat and offal
        1
        day
      • Egg
        no withdrawal period
    • Cattle (calf)
      • Meat and offal
        12
        day
    • Turkey
      • Meat and offal
        2
        day
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Finland
Package description:
  • Bucket : white polypropylene square c ontainer provided with a polypropylene lid. The buckets contains 4 kg of product.
  • Bucket : white polypropylene square c ontainer provided with a polypropylene lid. The buckets contains 1 kg of product.
  • Bucket : white polypropylene square c ontainer provided with a polypropylene lid. The buckets contains 5 kg of product.
  • Securitainer: white polypropylene cylindrical container provided with a low density polyethylene lid. The securitainer contains 800 g of product.
  • Securitainer: white polypropylene cylindrical container provided with a low density polyethylene lid. The securitainer contains 1000 g of product.
  • Securitainer: white polypropylene cylindrical container provided with a low density polyethylene lid. The securitainer contains 100 g of product.
  • Composi te can: h ardboard can provided with an inner lining of aluminium paper (poyethylene olyethylene terephthalate coated) and a seamed tin plate bottom, closed with a low density polyethylene lid. The can contains 550 g of product.
  • Securitainer: white polypropylene cylindrical container provided with a low density polyethylene lid. The securitainer contains 550 g of product.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dopharma Research B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dopharma B.V.
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 41178
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0189/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Sweden

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 10/05/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 10/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."